In-depth Analysis

  • The Campfire Stories of I...
    In part one of a two-part series, seasoned IP practitioners share with Michelle Ko notewor...
  • Chinese Pharmaceutical La...
    2017 could easily be one of the most impactful years for pharmaceutical development in Chi...
  • Collection of Evidence of Infringement in...
    Chinese law provides for particular measures to help the IP right owners obtain evidence so that their IP rights can be protected effectively. Deqiang...
  • Ready License One
    Before Chucky, Gundam, King Kong, T-Rex, Godzilla, etc., could appear in blockbuster Ready Player One, they had to be licensed first. Johnny Chan spea...
  • Strategies for Trade Secrets Protection i...
    Whether or not confidentiality measures have been taken is an important step in determining whether a trade secret exists in China. Xia Zheng, Mengmen...
  • Can OEM Production be Regarded as Tradema...
    Can products manufactured in China and exported to foreign countries infringe upon a Chinaregistered trademark? Hao Chen and Haiyan Wu explain.
  • To Be (Listed) or Not to Be
    “To be or not to be” is what Hamlet famously asks himself, but Slater & Gordon may have given the existential question a legal twist, reports Michelle...
  • I’ll See You in Court…?
    A major step has been taken to promote Hong Kong as a centre for global dispute resolution and Asia-Pacific’s premier IP trading hub; Michelle Ko expl...
  • The Best of the Best: Litigation
    After extensive consultation with corporate counsel, we present you 26 litigators in 13 jurisdictions around the Asia-Pacific region who we believe ar...
  • Best Feature: The Shape of Pharma
    Hosted by Johnny Chan, this academy award winning article reveals everything from protection to challenges of pharmaceutical patents.
more